Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise, and most importantly, imperiling the health and lives of patients. The Committee on Security of America's Medical Supply Chain, convened by the National Academies of Sciences, Engineering, and Medicine, was charged with addressing this important issue by examining the root causes of medical product shortages and ...
Read More
Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise, and most importantly, imperiling the health and lives of patients. The Committee on Security of America's Medical Supply Chain, convened by the National Academies of Sciences, Engineering, and Medicine, was charged with addressing this important issue by examining the root causes of medical product shortages and identifying ways to enhance their resilience - both in so-called normal times and during public health emergencies. Building Resilience into the Nation's Medical Product Supply Chains outlines the committee's seven recommendations and presents a framework of protection comprising awareness, mitigation, preparedness, and response measures. Table of Contents Front Matter Summary PART I: OVERVIEW OF GLOBAL MEDICAL PRODUCT SUPPLY CHAINS 1 Introduction 2 Understanding Medical Product Supply Chains 3 Globalization of U.S. Medical Product Supply Chains 4 Causes and Consequences of Medical Product Supply Chain Failures PART II: MEASURES FOR ENHANCING THE RESILIENCY OF MEDICAL PRODUCT SUPPLY CHAINS 5 A Framework for Resilient Medical Product Supply Chains 6 Awareness Measures for Resilient Medical Product Supply Chains 7 Mitigation Measures for Resilient Medical Product Supply Chains 8 Preparedness Measures for Resilient Medical Product Supply Chains 9 Response Measures for Resilient Medical Product Supply Chains Appendix A: Study Methods and Public Agendas Appendix B: Summary of Recommendations from Contemporary Reports Appendix C: Determining Risk Values When Evaluating Medical Product Supply Chain Resilience Appendix D: Commissioned Economic Analysis Appendix E: Committee and Staff Biosketches Appendix F: Disclosure of Unavoidable Conflict of Interest
Read Less
